7 In the index

Exemestane Aroma

An FDA-approved breast cancer drug that lowers estrogen, also used off-label by steroid users to manage estrogen levels. Its cancer use is well proven, but lowering estrogen this way can cause joint pain and bone loss over time.

Also known as Aromasin, 6-Methyleneandrosta-1,4-diene-3,17-dione, Exemestano, Exemestanum, NY22HMQ4BX, CHEBI:4953, examestane

Effects Hormonal

Routes Oral

Legal status Prescription drug

WADA Banned at all times

3D Molecular Structure of C₂₀H₂₄O₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C20H24O2
Molar mass: 296.4
CAS: 107868-30-4
PubChem CID: 60198
IUPAC name: (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
InChIKey: BFYIZQONLCFLEV-DAELLWKTSA-N

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 25 mg/day

Reported range 25 mg/day (standard); off-label bodybuilding doses sometimes lower and intermittent

Route Oral

Frequency Once daily

Duration Chronic (oncology) or cycle-length (off-label bodybuilding use)

FDA-approved aromatase inhibitor (Aromasin) for breast cancer; also used off-label by steroid users to control estrogen.

Where this comes from FDA prescribing information; off-label user-reported dosing

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.